MediFind
LoginSign Up
Are we missing a condition or feature you’d like to see? MediFind is always evolving and we’d love your feedback.
MediFind
Condition

Hyperlipoproteinemia Type 4

Symptoms, Doctors, Treatments, Research & More

Condition 101

What are the alternative names for Hyperlipoproteinemia Type 4?

  • Carbohydrate inducible hyperlipemia
  • Familial type IV hyperlipoproteinemia
Learn More About This Condition

Top Global Doctors

RS
Elite
Raul D. Santos
Sao Paulo, SP, BR
GW
Elite
Gerald F. Watts
Perth, WA, AU
JK
Elite
John J. Kastelein
Amsterdam, NH, NL
MS
Elite
Mariko Shiba-Harada
Suita, 27, JP
SH
Elite
Steve E. Humphries
London, ENG, GB
EB
Elite
Eric Bruckert
Paris, 11, FR
View All Doctors

Latest Research

Latest Advance
Study
  • Condition: Familial Hypercholesterolemia
  • Journal: Current atherosclerosis reports
  • Treatment Used: Statin Therapy
  • Number of Patients: 0
  • Published —
This article discusses advances in the use of statins for the treatment of familial hypercholesterolemia (FH).
Latest Advance
Study
  • Condition: Familial Hypercholesterolemia
  • Journal: Nutrients
  • Treatment Used: Cholesterol-Lowering Diet
  • Number of Patients: 376
  • Published —
This study investigated the impact of cholesterol-lowering diet in patients with familial hypercholesterolemia (high cholesterol).
Latest Advance
Study
  • Condition: Homozygous Familial Hypercholesterolemia
  • Journal: The New England journal of medicine
  • Treatment Used: Evinacumab
  • Number of Patients: 65
  • Published —
This study evaluated the effectiveness of evinacumab for patients with homozygous familial hypercholesterolemia (disease resulting from mutations in both copies of the low-density lipoprotein receptor gene).
Latest Advance
Study
  • Condition: Familial Chylomicronemia Syndrome (FCS) or Hypertriglyceridemia
  • Journal: Drug design, development and therapy
  • Treatment Used: Volanesorsen
  • Number of Patients: 0
  • Published —
This article discusses volanesorsen in the treatment of familial chylomicronaemia syndrome (FCS), a rare disorder of lipid metabolism characterized by high levels of triglycerides (TGs).
View All Latest Research

Clinical Trials

Clinical Trial
Biological
  • Status: Recruiting
  • Study Type: Biological
  • Participants: 60
  • Start Date: February 18, 2020
Familial Hypercholesterolemia Non Invasive Detection in Children by Salivary Test
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 148
  • Start Date: December 20, 2019
A Study to Evaluate Safety and Efficacy of IBI306 in Patients With Heterozygous Familial Hypercholesterolemia
Clinical Trial
Other
  • Status: Active, not recruiting
  • Participants: 100
  • Start Date: December 4, 2019
Clinical and Laboratory Assessment Study of Patients With a Clinical Presentation Consistent With Homozygous Familial Hypercholesterolemia (HoFH)
Clinical Trial
Biological
  • Status: Recruiting
  • Study Type: Biological
  • Participants: 30
  • Start Date: September 29, 2019
Phase 2b/3 Study to Assess the Efficacy and Safety of IBI306 in Subjects With Homozygous Familial Hypercholesterolemia. Part 1 - Open-label, Two-arm, Multicenter Pilot Study to Evaluate Efficacy and Safety of IBI 306 in Subjects With Homozygous Familial Hypercholesterolemia. Part 2 - Open-label, Single-arm, Multicenter Study to Evaluate Efficacy and Safety of IBI 306 in Subjects With Homozygous Familial Hypercholesterolemia
View All Clinical Trials